60
Participants
Start Date
November 20, 2021
Primary Completion Date
January 31, 2023
Study Completion Date
May 31, 2023
RECRUITING
Xuanwu Hospital, Beijing
Collaborators (3)
H. Lundbeck A/S
INDUSTRY
Hoffmann-La Roche
INDUSTRY
Genentech, Inc.
INDUSTRY
Life Molecular Imaging SA
INDUSTRY
APRINOIA Therapeutics
INDUSTRY
XINGIMAGING LLC
UNKNOWN
Hangzhou G-Bio Biotechnology Co., Ltd
UNKNOWN
Xuanwu Hospital, Beijing
OTHER